Jane Street Group, LLC Vaxart, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.58 - $0.99 $10,324 - $17,622	17,800 New	17,800 $15,000
Q1 2022 May 17, 2022	SELL	$4.29 - $6.64 $1.2 Million - $1.86 Million	-280,700 Reduced 66.14%	143,700 $724,000
Q4 2021 Feb 15, 2022	BUY	$5.77 - $7.96 $144,827 - $199,796	25,100 Added 6.29%	424,400 $2.66 Million
Q3 2021 Nov 16, 2021	SELL	$6.67 - $9.8 $1.58 Million - $2.32 Million	-236,500 Reduced 37.2%	399,300 $3.17 Million
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $1.97 Million - $4.21 Million	390,200 Added 158.88%	635,800 $4.76 Million
Q1 2021 May 18, 2021	SELL	$5.64 - $23.33 $206,988 - $856,210	-36,700 Reduced 13.0%	245,600 $1.49 Million
Q4 2020 Feb 17, 2021	SELL	$3.5 - $7.98 $752,150 - $1.71 Million	-214,900 Reduced 43.22%	282,300 $1.61 Million
Q3 2020 Nov 17, 2020	BUY	$4.78 - $16.97 $2.38 Million - $8.44 Million	497,200 New	497,200 $3.31 Million

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $79.7M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.